Here's How Abbott Labs Hit a Home Run With Its Q4 Results

Here's How Abbott Labs Hit a Home Run With Its Q4 Results

Abbott Laboratories (NYSE: ABT) made its shareholders quite happy last year with a market-beating stock price gain of 26%. The picture got even better on Wednesday when Abbott announced its fourth-quarter 2020 and full-year results before the market opened. Abbott Labs reported revenue of $10.7 billion in the fourth quarter, a 29% year-over-year jump.